Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016



Rating:

Share or cite this content

Citations should be made in the following way:
Jakko van Ingen, Dirk Wagner, Jack Gallagher, Kozo Morimoto, Christoph Lange, Charles S. Haworth, R. Andres Floto, Jennifer Adjemian, D. Rebecca Prevots, David E. Griffith for the NTM-NET. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016

Member's Comments

No comment yet.

Related content which might interest you: Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020 New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Source: Virtual Congress 2020 – German programme 2020 Year: 2020 Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018 Year: 2019 New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018 Pulmonary nontuberculous mycobacterial diseases Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Pulmonary nontuberculous mycobacterial diseases Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Pulmonary nontuberculous mycobacterial diseases Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement Source: Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018 Year: 2018 Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Cure rates in nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017 Patient reported outcomes for non-tuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019 Year: 2020 Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008 Diagnosis and treatment‘s management of the MDR tuberculosis in a chronic pulmonary diseases department Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005